Superior Planning, LLC’s Olema Pharmaceuticals OLMA Stock Holding History

Superior Planning, LLC’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$43	Buy	+5	New	+$54	﹤0.01%	2115

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Superior Planning, LLC's OLMA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Olema Pharmaceuticals (OLMA) in Q3 2026: 5 shares worth $43. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings.

88 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

Superior Planning, LLC held 5 shares of Olema Pharmaceuticals worth $43 as of Q3 2026.
Olema Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Olema Pharmaceuticals made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #2115 holding.
88 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.